# Prevention and Treatment of Patient Before, During, and After Covid-19 Infection

> **NCT05043324** · PHASE4 · COMPLETED · sponsor: **Nguyen Thi Trieu, MD** · enrollment: 82 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** AntiCov-220
- **DRUG:** AntiCov-220 (placebo)

## Key facts

- **NCT ID:** NCT05043324
- **Lead sponsor:** Nguyen Thi Trieu, MD
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-20
- **Primary completion:** 2022-04-20
- **Final completion:** 2022-04-27
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05043324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05043324, "Prevention and Treatment of Patient Before, During, and After Covid-19 Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05043324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*